Foremost experts to unite on diabetes focused online community-based learning and collaboration microsite
WorldOne, the global leader in healthcare data collection, insights and intelligence, and Joslin Diabetes Center, the world’s largest diabetes research and clinical care organization, today announced the upcoming launch of the Diabetes HUB, designed to inform and advance the quality and efficiency of diabetes care. Part of Joslin’s year-round Innovation leadership commitment, the online clinical and educational resource will be housed on Sermo, enabling close collaboration and information sharing between diabetes experts. The organizations jointly made the announcement today at the Diabetes Innovation 2013 annual conference in Washington, D.C.
“This partnership creates real opportunities for innovation in diabetes, a disease that is growing rapidly and needs new and creative solutions,” said John Brooks, CEO, Joslin Diabetes Center. “All of us at Joslin are very excited that the union of the two companies, and the strength, scope, and reach of the Diabetes HUB, will be a unique force for better health and wellness aligned with our other efforts such as the Diabetes Innovation event and the Diabetes Innovation Alliance, which encourages year round collaboration and action.”
Earlier this year, WorldOne introduced its HUB offering on Sermo with the launch of the MS HUB. Accessible to all 200,000 Sermo members, HUBs provide a virtual learning and collaboration space for practicing physicians to tackle some of health care’s biggest challenges. HUBs for additional therapeutic areas will be added in coming months.
“The HUB is a novel way to improve healthcare by furthering clinical knowledge and encouraging collaboration through an interactive forum designed specifically for physicians,” said Peter Kirk, Founder and CEO of WorldOne. “The Diabetes HUB will be enhanced by Joslin’s thought leadership and expertise, ensuring we are the ultimate physician resource on diabetes care.”
In addition to providing an interactive forum for physicians to discuss and debate posts by Sermo opinion leaders, the Diabetes HUB features Joslin’s educational offerings, point of care tools and resources, as well as authoritative curated content from select sources. Joslin will also poll HUB participants on a variety of topics, aggregating physician insights on diabetes care and prevention. To maximize the educational opportunity, Joslin clinicians will help spark dialogue and reflect key findings back into the community as well as other key stakeholders in Diabetes care. Joslin’s committed educational network of over 130,000 primary care providers will be invited to participate consistently and to join Sermo, which is free and exclusive to practicing MD’s licensed in the U.S.
WorldOne and Joslin also released intelligence from their most recent joint survey, a follow up to their emerging diabetes trends survey of WorldOne primary care physicians and endocrinologists, as well conference delegates, which was released last year at Diabetes Innovation 2012. A summary of findings and other conference highlights can be found at www.Sermo.com/di2013.
WorldOne is the global leader in healthcare data collection, insights and intelligence. Headquartered in New York with 18 regional offices across North America, South America, Europe and Asia-Pacific, WorldOne brings online and offline access to medical professionals through a range of differentiated products and services. In July 2012, WorldOne acquired Sermo, the largest online physician community in the United States, to provide an expanded platform for its Global Networked Community comprising over 1.8 million healthcare professionals spanning 80 countries, including more than 385,000 U.S. physicians. For more information visit: www.worldone.com.
About Joslin Diabetes Center
Joslin Diabetes Center, based in Boston, Massachusetts, undertakes diabetes research, clinical care, education and health and wellness programs on a global scale. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real progress in preventing and curing diabetes. Joslin is an independent, nonprofit institution affiliated with Harvard Medical School, and is recognized worldwide for driving innovative solutions in diabetes prevention, research, education, and care. Our mission is to prevent, treat and cure diabetes. Our vision is a world free of diabetes and its complications. For more information, visit www.joslin.org.
About Diabetes Innovation
Diabetes Innovation, now in its second year, is an annual congress that anchors the year round innovation effort of Joslin Diabetes Center and is the featured global activity of the Joslin Diabetes Innovation Alliance, a group of leading organizations and individuals from all stakeholder groups committed to producing unique solutions and collaborations in diabetes care and prevention. For more information, visit www.diabetesinnovation.org.